Cargando…

Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod

Current treatment for Multiple Sclerosis (MS) consists of a multidisciplinary approach including disease-modifying therapies. The response to treatment is heterogeneous, representing a crucial challenge in the classification of patients. Metabolomics is an innovative tool that can identifies biomark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murgia, Federica, Lorefice, Lorena, Noto, Antonio, Spada, Martina, Frau, Jessica, Fenu, Giuseppe, Coghe, Giancarlo, Gagliano, Antonella, Atzori, Luigi, Cocco, Eleonora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056460/ https://www.ncbi.nlm.nih.gov/pubmed/36984868 http://dx.doi.org/10.3390/metabo13030428

Ejemplares similares

Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023)

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)

Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the World
por: Frau, Jessica, et al.
Publicado: (2021)

(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
por: Lorefice, Lorena, et al.
Publicado: (2023)

Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
por: Murgia, Federica, et al.
Publicado: (2020)

The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases
por: Frau, Jessica, et al.
Publicado: (2023)

Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study
por: Lorefice, Lorena, et al.
Publicado: (2021)

Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis
por: Coghe, Giancarlo, et al.
Publicado: (2019)

What do multiple sclerosis patients and their caregivers perceive as unmet needs?
por: Lorefice, Lorena, et al.
Publicado: (2013)

Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers
por: Pau, Massimiliano, et al.
Publicado: (2020)

Brain Volume and Perception of Cognitive Impairment in People With Multiple Sclerosis and Their Caregivers
por: Fenu, Giuseppe, et al.
Publicado: (2021)

Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study
por: Pau, Massimiliano, et al.
Publicado: (2022)

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility
por: Lorefice, Lorena, et al.
Publicado: (2021)

Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population
por: Cocco, Eleonora, et al.
Publicado: (2013)

(1)H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome
por: Gagliano, Antonella, et al.
Publicado: (2022)

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers
por: Fenu, G., et al.
Publicado: (2018)

A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls
por: Frau, Jessica, et al.
Publicado: (2018)

Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives
por: Lorefice, Lorena, et al.
Publicado: (2023)

An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis
por: Fronza, Marzia, et al.
Publicado: (2021)

Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
por: Frau, J., et al.
Publicado: (2016)

Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review
por: Murgia, Federica, et al.
Publicado: (2022)

Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
por: Spada, Martina, et al.
Publicado: (2023)

Metabolomic profile of systemic sclerosis patients
por: Murgia, Federica, et al.
Publicado: (2018)

What gait features influence the amount and intensity of physical activity in people with multiple sclerosis?
por: Pau, Massimiliano, et al.
Publicado: (2021)

Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis
por: Pau, Massimiliano, et al.
Publicado: (2015)

Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
por: Murgia, Federica, et al.
Publicado: (2021)

Metabolomic Investigation of β-Thalassemia in Chorionic Villi Samples
por: Monni, Giovanni, et al.
Publicado: (2019)

The impact of secondary infections in COVID-19 critically ill patients
por: Murgia, Federica, et al.
Publicado: (2022)

Alterations of the Intestinal Permeability are Reflected by Changes in the Urine Metabolome of Young Autistic Children: Preliminary Results
por: Piras, Cristina, et al.
Publicado: (2022)

HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
por: Cocco, Eleonora, et al.
Publicado: (2012)

Metabolomics in Prenatal Medicine: A Review
por: Monni, Giovanni, et al.
Publicado: (2021)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Gait and Functional Mobility in Multiple Sclerosis: Immediate Effects of Transcranial Direct Current Stimulation (tDCS) Paired With Aerobic Exercise
por: Pilloni, Giuseppina, et al.
Publicado: (2020)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

Walking in multiple sclerosis improves with tDCS: a randomized, double‐blind, sham‐controlled study
por: Pilloni, Giuseppina, et al.
Publicado: (2020)

Metabolomics As a Tool for the Characterization of Drug-Resistant Epilepsy
por: Murgia, Federica, et al.
Publicado: (2017)

Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study
por: Kumar, Amit, et al.
Publicado: (2013)

Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles
por: Cocco, Eleonora, et al.
Publicado: (2012)

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
por: Laroni, Alice, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dsmmjv7aq1esls92iu7e526mu8